Latest from Companies

Market close: NZ shares edge ahead, F&P Healthcare rebounds

The S&P/NZX 50 Index edged ahead in a quiet end to the week.

Air NZ Covid case: Was crew member infected during earlier Shanghai mission?

Airline doctor says infection first for Air NZ in 7.5 months, source may never be known.

Jarden Brief: TikTok owner running out of time to sell or face US ban

Jarden's daily update on the latest market moves and shakes.

Loyalty wars: Qantas swoops on flyers from other airline schemes

Switcheroo: Airline hoping to poach flyers from other loyalty schemes, including Air NZ.

Market close: NZ shares fall as Kiwi dollar weighs on market

The fast-rising NZ dollar began weighing on the New Zealand sharemarket.

Analysts ponder F&P Healthcare in a post-Covid world

F&P Healthcare's first-half profit leapt by 86 per cent, driven by Covid-19 demand.

Gentrack sinks deeper into red as Covid-19 bites

Software provider Gentrack has sunk deeper into the red over the September year.

Even in a pandemic, the billionaires are winning

New York Times: In the worst economic crisis since the 1930s, billionaires' wealth grew.

Sylvia Park owner releases financial results, reveals Covid impact

$3.2b landlord's first-half result out.

Air NZ's Airpoints better earner than its airplanes - analysts

The estimated $725m value of Airpoints could be used as collateral in capital raise.

Cream of the crop? Fonterra's new chairman tells it like it is

Fonterra's new chairman "challenges everything".

A2 Milk plays up its Kiwi-ness as Chinese-Aussie ties sour

A2 Milk treads Kiwi line as relations between Australia and China grow ever more hostile.

What the pandemic cost Ryman Healthcare

Company bought four Alpaure AP4 sterilising fog machines for $1m - MacLeod.

Market close: NZX takes late dive, Ryman and F&P Healthcare fall

The New Zealand sharemarket fell nearly one per cent.

Jarden Brief: How Covid-19 surge is affecting US markets

Jarden's daily update on the latest market moves and shakes.

Ryman spends $50m on pandemic response

First half-year results out for NZ's biggest listed retirement business